Virt-pn Plus Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Warning: This product contains FD&C Yellow #5 and FD&C Blue #1.
Daily ingestion of more than 3 g per day of omega-3 fatty acids (ALA, EPA, and DHA) from fish oils may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids − including DHA, should be avoided in patients with inherited or acquired bleeding diatheses, including those taking anticoagulants.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Virt-PN Plus is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.
There is currently no drug history available for this drug.
Virt-PN Plus is a prescription prenatal/postnatal multivitamin/mineral softgel with an essential fatty acid.
|Each softgel has the following active ingredient:|
(L-methylfolate, or 6(S)-5-MTHF 600 mcg)
(folic acid, USP 400 mcg)
|Each softgel also contains the following ingredients |
for nutritional supplementation:
|Vitamin C||85 mg|
|Vitamin D3||200 IU|
|Vitamin E||10 IU|
|Vitamin B6||25 mg|
|Vitamin B12||12 mcg|
|Calcium (calcium carbonate)||140 mg|
|Iron (ferrous fumarate)||28 mcg|
|Iodine (potassium iodide)||150 mcg|
|Magnesium (magnesium oxide)||45 mg|
|Docosahexaenoic Acid (DHA)||300 mg*|
|Eicosapentaenoic Acid (EPA)||40 mg*|